Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1.376
1.303 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$213,52 |
-1%
|
$377,67 B |
|
|
|
Amgen Inc
AMGN
|
$339,51 |
+0,1%
|
$183,23 B |
|
|
|
Gilead Sciences Inc
GILD
|
$135,155 |
+0,6%
|
$167,76 B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$440,81 |
+1,4%
|
$112,12 B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$630,285 |
-1,3%
|
$66,63 B |
|
|
|
argenx SE
ARGX
|
€710 |
+0,6%
|
$51,15 B |
|
|
|
Alnylam Pharmaceuticals Inc
ALNY
|
$295,61 |
-0,6%
|
$39,44 B |
|
|
|
CSL Ltd
CSL
|
AU$97,845 |
-0,6%
|
$34,06 B |
|
|
|
Beigene Ltd
6160
|
HK$182,8 |
-0,9%
|
$31,80 B |
1.298 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
